6-(4-取代苯基)-5-甲基-4,5二氢-3(2H)哒嗪酮化合物的合成及其抑制血小板聚集作用

血小板聚集在血栓形成中起着先导而关键的作用,而严重威胁人类生命健康的心脑血管疾病多数与血栓形成和血栓栓塞有着密切的联系[1]。二氢哒嗪酮类化合物对抑制血小板聚集有较强的药理活性,对二磷酸腺苷(ADP)、花生四烯酸(AA)、血小板活化因子(PAF)和胶原(Collagen)引起的血小板聚集均有抑制作用。深入研究二氢哒嗪酮类化合物的构效关系,以期寻找活性更强的抗血小板聚集药物,是开发新型心脑血管系统疾病药物的重要研究方向之一。本文设计合成了6-(4-取代苯基)-5-甲基-4,5二氢-3(2H)哒嗪酮类化合物[2,3,4],并进行了体外药理实验。1实验部…     

4-氟-3-羟基-1-取代苯基-6-哒嗪酮及其衍生物的合成

报导4-氟-3-羟基-1-取代苯基-6-哒嗪酮及其衍生物的合成,氟代顺丁烯二酸酐和取代苯肼类反应的研究结果及部分化合物的药理实验结果。     

1-甲基-3-芳基-6-三氟甲基哒嗪-4-酮类化合物的合成与生物活性

在现有原卟啉原氧化酶抑制剂构效关系基础上,设计了一类结构新颖的3-芳基哒嗪酮类化合物,并探索了该类化合物的合成方法,合成了9个3-芳基哒嗪酮类化合物,并用于开展室内除草活性测定和作物安全性评价.结果表明3-芳基哒嗪酮类化合物具有较高的芽前、芽后除草活性和作物安全性.对高活性化合物3-[2,4-二氯-5-(环戊氧基)苯基]-1-甲基-6-(三氟甲基)哒嗪-4(1H)-酮(Ie)进行了苗后玉米田间小区药效验证试验,结果表明化合物Ie在60 g a.i./hm2剂量下的总草防效略高于105 g a.i./ha用量的硝磺草酮,且对苗后玉米安全.     

噁二唑衍生物的合成研究

以苯甲酸乙酯和水合肼为初始原料,经过肼解、酰化、关环反应合成2-氯甲基-5-苯基-1,3,4-噁二唑,与4,5-二氯-3(2H)-哒嗪酮反应合成中间体4,5-二氯-2-[(5-苯基-1,3,4-噻二唑-2)-甲基]-哒嗪酮,再与胺类等化合物通过取代反应合成一系列目标化合物。所有化合物的结构通过1HNMR、IR和元素分析确证。     

4-氟-1,2-二氢-3,6-哒嗪二酮及其衍生物的合成

本文报导了4-氟-1,2-二氢-3,6-哒嗪二酮(Ⅱ)及其衍生物3,6-二氯-4-氟哒嗪(Ⅲ)、3-甲氧基-4-氟-6-氯哒嗪(Ⅳ)、3-邻甲苯氧基-4-氟-6-氯哒嗪(Ⅵ)、1-苯基-3-羟基-4-氟-6-哒嗪酮(Ⅶ)等五种新化合物的合成,探讨了(Ⅲ)同亲核试剂的反应性能和部分化合物的药理实验结果.     

含吲哚啉酮取代基的噻唑酮类化合物的合成及其抗菌活性研究

目的：合成一系列含吲哚啉酮骨架的噻唑酮类化合物并对其进行抗耐药白念珠菌活性筛选。方法：以不同取代基的4-苯基噻唑-2(3H)-酮和不同取代的2-苯基-3H-吲哚-3-酮为起始原料,进行Friedel-Crafts烷基化反应,优化并合成一系列目标衍生物,并采用微量稀释法对合成的化合物进行了抗真菌活性研究。结果与讨论：报道了一种新型合成含吲哚啉酮取代基的噻唑酮类化合物的方法,优化反应条件后以良好至优秀的产率得到了22个化合物。微量稀释法测试结果显示,合成的化合物其效果除了化合物17,18效果较差以外,其余20个化合物效果优秀,值得进一步探讨和研究。     

新型色酮衍生物的合成及其抗胃癌细胞(SGC-7901)活性

取代苯甲醛与取代2-羟基苯乙酮缩合形成α,β-不饱和酮(4a~4 f);4用H2O2氧化关环制得取代-3-羟基-2-取代苯基色酮(5a~5 f);5与2-氯-5-氯甲基吡啶反应合成了6个新型的含二氯五氯甲基吡啶结构的色酮类衍生物(6a~6 f),其结构经1H NMR,13C NMR和元素分析表征。初步体外活性实验结果表明,部分化合物具有较好的抗胃癌细胞(SGC-7901)活性。     

2-取代-6-甲基-4-苯基-3(2H)-哒嗪酮类化合物的合成及除草活性研究

设计合成了一系列文献中未报道的2-取代-6-甲基-4-苯基-3(2H)-哒嗪酮类化合物,其结构经过1H NMR和元素分析确证,化合物4e进行了X射线衍射晶体结构分析.利用油菜平皿法和稗草小杯法对化合物进行了生物活性的测定.初步生物活性测试结果表明,化合物4具有较好的除草活性.定量构效关系表明,化合物4结构中哒嗪环2-位取代基的变化,影响了化合物的抑制活性.当作用对象为油菜时,化合物的活性可能主要与取代基R的立体参数B4和疏水性有关;当作用对象为稗草时,化合物的活性可能主要与取代基R的疏水性有关.部分化合物4的抑制活性与对照药品5b,5k基本相当,但没有表现出5b,5k所具有的白化效果.化合物4与5这两类结构类似的化合物很可能在生物体内拥有不同的作用机制.     

新型三唑并[4,5-d]嘧啶类化合物的合成及其抗血小板聚集活性

以2-丙硫基-4,6-二氯-5-氨基嘧啶为原料,与伯胺类化合物(1)经取代反应制得氨基嘧啶类化合物(2);2经重氮化反应制得三氮唑类化合物(3);3与胺类化合物经亲核取代反应和水解反应合成了26个新型的三唑并[4,5-d]嘧啶类化合物(6a~6z),其结构经1H NMR和ESI-MS表征。大鼠体内抗血小板聚集模型测试结果表明:26个化合物均具有一定的抗血小板聚集活性,其中,6d,6i和6l的抗血小板聚集活性较强,抑制率分别为61.9%,69.3%和71.2%。     

糖苷合成研究(ⅩⅩⅠ)2-N-(β-D-吡喃葡萄糖-1-基)-6-(4-卤代苯基)-3-哒嗪酮的合成

在相转移催化条件下,2,3,4,6-四-O-乙酰基-1-溴-1-脱氧-α-D-吡喃葡萄糖1与6-(4-卤代苯基)-3(2H)-哒嗪酮2反应,合成了4种新的哒嗪酮葡萄糖苷3;然后用干燥的氨气在0～-5 ℃下处理,得相应的2-N-(β-D-吡喃葡萄糖-1-基)-6-(4-卤代苯基)-3-哒嗪酮4. 这些化合物的结构经IR、1H NMR、13C NMR及元素分析所证实.     

1-(4-取代苯基)-4-苯基-5-(2-羟基苄基)氨基-1,2,3-三唑类衍生物的合成及抑菌活性

将邻羟苯基引入1,2,3-三唑结构中, 设计合成了10个1-(4-取代苯基)-4-苯基-5-取代-1,2,3-三唑类衍生物. 首先, 以对位取代的芳胺为原料, 经重氮化、叠氮化、闭环和缩合反应制得1-(4-取代苯基)-4-苯基-5-水杨醛亚胺-1,2,3-三唑类衍生物(3a~3e), 再用硼氢化钠还原制得1-(4-取代苯基)-4-苯基-5-(2-羟基苄基)氨基-1,2,3-三唑类衍生物(4a~4e). 目标化合物的结构经核磁、IR及元素分析确认. 抑菌活性测试表明, 当质量浓度为0.1 mg/L时, 除化合物3e和4e外, 所有化合物对白色念球菌的抑菌率均达95%以上, 对大肠杆菌的抑菌率达85%以上, 具有强抑菌活性, 表明该类化合物在抗菌药物开发方面有重要应用价值.     

新型1,2,3-三唑类化合物的合成及抗菌构效关系

根据活性基团拼接原理, 以4-取代-苯胺为原料, 经重氮化、 关环和缩合反应合成了17个化合物1-(4-取代苯基)-5-取代苯基亚氨基-4-取代-1,2,3-三唑(7a~7c和13a~13d)和1-(4-取代苯基)-5-取代苄基氨基-4-取代-1,2,3-三唑(5a~5c, 10a~10c和14a~14d), 其中化合物5a~5c, 7b, 7c, 10a, 10c, 13b~13d和14b~14c为新化合物, 对所制备化合物的结构进行了表征. 生物活性测试结果表明, 所有化合物均表现出一定的抑菌活性, 对大肠杆菌的抑菌活性均优于氟康唑; 化合物7a和10c对金黄色葡萄球菌的抑制活性明显优于氟康唑; 而化合物13a和13d则对白色念球菌表现出良好的抑制活性, 与三氯生相当.     

Studies on new platelet aggregation inhibitors 1. Synthesis of 7-nitro-3,4-dihydroquinoline-2(1H)-one derivatives.

A series of 6-cyclic aliphatic amino-7-nitro-3,4-dihydroquinoline-2(1H)-ones were prepared and tested for platelet aggregation inhibitory effect, cardiotonic activity and chronotropic activity. These compounds appeared to show selective inhibitory activity against platelet aggregation. Among them, 6-(4-ethoxycarbonylpiperidino)-7-nitro-3,4-dihydroquinoline-2(1H)-one (22f) showed the most potent inhibitory activity and high selectivity. A divergent synthetic route to 6-cyclic aliphatic amino-7-nitro-3,4-dihydroquinoline-2(1H)-one derivatives has also been investigated.     

An efficient synthesis of designed 4-thiazolidinone fused pyrimidine derivatives as potent antimicrobial agents

A novel series of hybrid 2-substituted ((pyrimidin-2-yl)hydrazinyl)thiazolidin-4-one derivatives were synthesized by means of aromatic nucleophilic displacement of chlorine atoms of 2,4,6-trichloro pyrimidine. Synthesis of some novel 2-(2-(6-morpholino-4-substituted(phenyl amino)pyrimidin-2-yl)hydrazinyl)thiazol-4(5H)-one derivatives have been carried out by the displacement of chlorine atoms on the basis of functionality concept on varying conditions. The synthesized hydrazinyl thiazolidin-4-one pyrimidine derivatives were evaluated for their expected antimicrobialactivity; where, the majority of these compounds showed potent antibacterial and antifungal activities against the tested strains of bacteria and fungi. Afforded title analogs were subsequently characterized by elemental analysis, IR, ¹H NMR, ¹³C NMR, Mass spectroscopy. SAR and HOMO-LUMO studies were also carried out for confirming the structure biological activity. Thus, these studies suggested that hydrazinyl pyrimidine derivatives bearing thiazolidinone moiety are interesting scaffolds for the development of novel antimicrobial agents.     

Synthesis and antiulcer activity of 4-substituted 8-[(2-benzimidazolyl)sulfinylmethyl]-1,2,3,4-tetrahydroquinoli nes and related compounds

A series of 4-substituted 8-[(2-benzimidazolyl)sulfinylmethyl]-1,2,3,4-tetrahydroquinolin es was synthesized and examined for their (H+ + K+)adenosine triphosphatase (ATPase)-inhibitory and antisecretory activities against histamine-induced gastric acid secretion in rats. Many compounds tested were potent inhibitors of (H+ + K+)ATPase. Most compounds showed antisecretory activity. The antiulcer activity against water-immersion stress-induced gastric ulcer, aspirin-induced gastric ulcer and gastric necrosis induced by hydrochloric acid also were tested in the rat. Some of these compounds, in particular, 4-(N-allyl-N-methylamino)-1-ethyl-8-[(5-fluoro-6-methoxy-2-benzimidazoly l) sulfinylmethyl]-1-ethyl-1,2,3,4-tetrahydroquinoline (XVIIx) were found to have potent activity. The structure-activity relationships are discussed.     

2-{2-[3-(取代苯基)-3-氧代-2-1,2,4-三唑-1-基-丙基]-苯基}-2-甲氧亚氨基乙酸甲酯和乙酰甲胺类衍生物的合成与杀菌活性研究

以2-甲基苯甲酰甲酸甲酯为起始原料, 通过与甲氧基胺的盐酸盐、甲胺、N-溴代丁二酰亚胺(NBS)和1H-1,2,4-三氮唑钠反应合成了两个系列共计22个2-{2-[3-(取代苯基)-3-氧代-2-1,2,4-三唑-1-基-丙基]-苯基}-2-甲氧亚氨基乙酸甲酯和乙酰甲胺类的衍生物. 经IR, 1H NMR和MS对目标化合物进行了结构表征. 用浓度为 10 µg•mL－1的目标化合物进行了初步离体杀菌活性试验, 结果表明: Ha4, Ha5, Ha7对油菜菌核病有杀菌活性; Ha2, Hb8对小麦纹枯病有杀菌活性; Hb4对蔬菜灰霉病有杀菌活性; Hb4, Hb5对小麦赤霉病和小麦纹枯病均有杀菌活性.     

Design,synthesis and antimicrobial activities of 1,2,3-triazole derivatives

Fifteen 1-(4-substituted phenyl)-4-(4-bromophenyl)-5-(halo-o-hydroxyphenyl)imino-1,2,3-triazoles were designed and synthesized based on rational combination of 1,2,3-triazoles and(halo)o-hydroxyphenyl group according to the superposition principle of reinforcement of biological activities.All the compounds were tested to an in vitro antimicrobial screening against M.a.and E.c..Compounds IIe-IIo exhibited more potent antimicrobial activities against M.a.and E.c.than triclosan and fluconazole,which provided valuable information to further study of novel antimicrobial research.     

3-取代硫基-5-(1-羟基苯基)-4H-1,2,4-三唑类化合物的合成及抑菌活性

依据邻羟基二苯醚及三唑类化合物的抗菌特性及生物活性叠加原理, 将邻羟苯基和1,2,4-三唑分子片断有机结合, 设计合成了12个新型3-取代硫基-5-(1-羟基苯基)-4H-1,2,4-三唑类化合物. 首先, 水杨酸甲酯与水合肼反应生成水杨酰肼, 水杨酰肼再与硫氰酸铵和盐酸反应, 生成5-(1-羟基苯基)-4H-1,2,4-三唑-3-硫酮(3), 最后在碱性条件下化合物3与取代苯乙酮、氯苄和碘甲烷发生烷基化反应生成目标化合物, 化合物结构经 1H NMR及IR等表征确认. 抑菌测试结果表明, 当化合物质量分数为0.01%时, 目标化合物对白色念珠菌和大肠杆菌的抑菌率高达90%, 具有强抑菌活性; 对金黄色葡萄球菌的抑菌率高达80%, 具有一定的抑菌活性.     

Synthesis and antimicrobial activity of some novel 5-alkyl-6-substituted uracils and related derivatives

6-chloro-5-ethyl-, n-propyl- and isopropyluracils 5a-c were efficiently prepared from the corresponding 5-alkybarbituric acids 3a-c via treatment with phosphorus oxychloride and N,N-dimethylaniline to yield the corresponding 5-alkyl-2,4,6-trichloro-pyrimidines 4a-c, which were selectively hydrolyzed by heating in 10% aqueous sodium hydroxide for 30 minutes. The reaction of compounds 5a-c with 1-substituted piperazines yielded the corresponding 5-alkyl-6-(4-substituted-1-piperazinyl)uracils 6a-j. The target 8-alkyltetrazolo[1,5-f]pyrimidine-5,7(3H,6H)-diones 7a-c were prepared via the reaction of 5a-c with sodium azide. Compounds 6a-j and 7a-c were tested for in vitro activities against a panel of Gram-positive and Gram-negative bacteria and the yeast-like pathogenic fungus Candida albicans. Compound 6h displayed potent broad-spectrum antibacterial activity, while compound 6b showed moderate activity against the Gram-positive bacteria. All the tested compounds were practically inactive against Candida albicans.